Capricor Therapeutics
CAPR
#7984
Rank
NZ$0.50 B
Marketcap
NZ$10.98
Share price
-4.36%
Change (1 day)
-57.33%
Change (1 year)

Capricor Therapeutics (CAPR) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.21 Billion

According to Capricor Therapeutics 's latest financial reports the company's total assets are NZ$0.21 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.30 B225.48%
2023-12-31NZ$92.87 M17.71%
2022-12-31NZ$78.9 M30.4%
2021-12-31NZ$60.5 M26.12%
2020-12-31NZ$47.97 M190.75%
2019-12-31NZ$16.5 M19.7%
2018-12-31NZ$13.78 M-39.84%
2017-12-31NZ$22.91 M-15.33%
2016-12-31NZ$27.06 M15.27%
2015-12-31NZ$23.47 M34.95%
2014-12-31NZ$17.39 M158.17%
2013-12-31NZ$6.73 M2.22%
2012-12-31NZ$6.59 M274.99%
2011-12-31NZ$1.75 M-63%
2010-12-31NZ$4.75 M-4.65%
2009-12-31NZ$4.98 M-55.06%
2008-12-31NZ$11.08 M-50.29%
2007-12-31NZ$22.31 M
2006-12-31N/A-100%
2005-12-31NZ$0 M-53.8%
2004-12-31NZ$0 M-46.39%
2003-12-31NZ$0 M3374.78%
2002-12-31NZ$0 M-91.84%
2001-12-31NZ$0 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Cytokinetics
CYTK
NZ$2.48 B 1,036.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$6.43 M-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$332.99 B 152,398.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.36 B 3,273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.11 B 412.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$10.65 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA